VELO Citrus 4mg
Best for: Adult users 21 and older new to nicotine pouches who want a bright citrus profile at entry-level strength from a major manufacturer.
Skip if: You want FDA-authorized regulatory clarity or prefer mint flavors; try ZYN Citrus 3mg or VELO Ice Cool 4mg instead.
💰 Where to Buy
3 retailers · Updated weekly* Affiliate links — we earn a small commission when you buy through these. No additional cost to you.
Hands-on Notes
Flavor profile
VELO Citrus 4mg delivers a bright citrus blend leading with orange and lemon notes over a moderately sweet base. The slightly moist pouch construction releases flavor inside the first minute and the citrus brightness peaks at 5-7 minutes. R.J. Reynolds Vapor's tobacco-derived nicotine formulation keeps the citrus profile clean without tobacco character. Adult users 21 and older familiar with juice-style citrus pouches will recognize the profile. The flavor stays present through 18 minutes before tapering to a milder citrus background note that persists until discard.
Strength
VELO Citrus 4mg sits at the entry tier of the VELO US lineup, below VELO Ice Cool 7mg and VELO Dryft Spearmint 7mg. Onset arrives at 4-6 minutes and stays mild for the full session. The 4mg load suits adult users 21 and older new to nicotine pouches or transitioning down from heavier products. Compared to ZYN Citrus 3mg, VELO delivers a similar nicotine load in a moister pouch with a slightly sweeter flavor profile.
Pros
VELO Citrus 4mg offers 20 pouches per can versus the 15 in ZYN cans. The bright orange-lemon profile suits adult users 21 and older new to fruit pouches. The slightly moist pouch design delivers fast flavor onset within the first minute. R.J. Reynolds Vapor's tobacco-derived nicotine formulation avoids synthetic-nicotine regulatory uncertainty.
Cons
VELO Citrus 4mg has submitted a PMTA but has not yet received FDA marketing authorization. The citrus profile leans sweeter than ZYN Citrus 4mg, which may not suit users seeking a tart or drier flavor. The single-note citrus profile lacks the complexity of layered fruit blends in competing brands.
Full Specifications
| Brand | VELO |
| Flavor | Citrus |
| Strength | 4 mg |
| Format | Slim |
| Pouches per can | 20 |
| Moisture | Slightly moist |
| Tobacco-free | Yes |
| Synthetic nicotine | No (tobacco-derived) |
| Manufacturer | R.J. Reynolds Vapor / British American Tobacco (BAT) |
| FDA Status | PMTA Submitted (Not Authorized as of May 2026) |
Common Questions
Is VELO Citrus 4mg FDA approved or authorized?+
VELO Citrus 4mg is not FDA authorized. Its FDA Status is: PMTA Submitted (Not Authorized as of May 2026). R.J. Reynolds Vapor and British American Tobacco have submitted premarket tobacco applications, but FDA has not granted marketing authorization for any VELO US SKU. As of June 2026, only ZYN and select on! PLUS variants hold FDA marketing orders.
How does VELO Citrus 4mg compare to other VELO strengths?+
VELO Citrus 4mg sits at the entry-level tier of the VELO US lineup. The 4mg tobacco-derived nicotine load delivers mild satisfaction with onset at 4-6 minutes. Adult users 21 and older new to nicotine pouches typically start at 4mg before evaluating 7mg variants like VELO Ice Cool 7mg.
What does VELO Citrus 4mg taste like compared to ZYN Citrus 4mg?+
VELO Citrus 4mg delivers a bright citrus blend in a slightly moist pouch versus ZYN Citrus 3mg's dry format. ZYN holds FDA marketing authorization while VELO does not. Both feature orange-lemon profiles; VELO leans sweeter, ZYN leans drier and more tangy.
How long does VELO Citrus 4mg last per pouch?+
VELO Citrus 4mg holds active flavor for 25-35 minutes with peak intensity in the first 10 minutes. The slightly moist pouch design delivers steady flavor release. The 4mg tobacco-derived nicotine load provides mild satisfaction throughout the session.
Can VELO Citrus 4mg help me quit smoking?+
VELO Citrus 4mg is not authorized for smoking cessation. FDA has not evaluated this product as a quit aid, and nicotine pouches are not approved alternatives to FDA-cleared nicotine replacement therapies. Adult users 21 and older seeking to quit should consult a healthcare provider about evidence-based options.